: He pointed to the government's decision not to appeal a Quebec Court of Appeal ruling that struck down several core pricing reforms, effectively "eviscerating" the government’s own policy.
Herder’s departure was prompted by what he described as the government’s "unwillingness to support real change" in drug pricing reform. His specific grievances included: : He pointed to the government's decision not
: Herder stated the government’s actions were "largely indistinguishable in form and substance from industry talking points," leaving the regulator in an "endless tunnel with no light". Context and Fallout : He pointed to the government's decision not
: He criticized then-Health Minister Jean-Yves Duclos for intervening on behalf of the pharmaceutical industry by asking the board to suspend consultations on new pricing guidelines. : He pointed to the government's decision not